NCT06240884

Brief Summary

It is proposed to investigate the effectiveness of ultrasound-guided intertrochanteric block of the infraspinatus minor round myofascial block not inferior to the interosseous groove brachial plexus nerve block in postoperative analgesia and overall quality of recovery in shoulder surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 8, 2023

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

January 2, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 5, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 5, 2024

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 12, 2024

Completed
Last Updated

July 3, 2024

Status Verified

June 1, 2024

Enrollment Period

4 months

First QC Date

January 2, 2024

Last Update Submit

June 30, 2024

Conditions

Keywords

Infraspinatus-teres minor (ITM) interfascial blockshoulder arthroscopy

Outcome Measures

Primary Outcomes (1)

  • Area under the NRS curve at rest during 0-24h postoperatively

    Anesthesiologists who were not aware of the study subgroups began to assess the analgesic effect of the patients' block at rest using the numeric pain rating scale (NRS) at 0.5h, 3h, 6h, 12h, 18h, and 24h postoperatively.Score range from 0 (no pain) to 10 (worst pain possible).

    0-24 hours after surgery

Secondary Outcomes (2)

  • Complications

    during 48 hours after operation

  • Asses The postoperative opioid consumption

    24 hours postoperatively

Study Arms (2)

Infraspinatus-teres minor interfascial block

EXPERIMENTAL

Patients will receive Infraspinatus-teres Minor Interfascial Block with 20 ml of 0.375% ropivacaine prior to induction of general anesthesia.

Procedure: Infraspinatus-teres minor interfascial block

interscalene block

ACTIVE COMPARATOR

The patient underwent an ultrasound-guided brachial plexus nerve block in the interosseous sulcus using 20 ml of 0.375% ropivacaine.

Procedure: interscalene block

Interventions

After identifying the infraspinatus and teres minor muscles on the posterior surface of the scapular neck. Under real-time ultrasound guidance, the needle is advanced into the interfascial plane between the infraspinatus and teres minor muscles using an in-plane technique, and after confirming the fascial opening with 3 to 5 mL of 0.375% ropivacaine (20 mL total dose), the remaining 0.375% ropivacaine is injected. After extubation and the patients were awake, anesthesiologists who were unaware of the study subgroups began to assess the analgesic effect of the patients' block at rest using the numeric pain rating scale (NRS) at 0.5h, 3h, 6h, 12h, 18h, 24h, and 48h postoperatively.

Infraspinatus-teres minor interfascial block

The tip of the needle was placed between the C5 and C6 nerve roots, and after a bloodless retraction with 0.5 to 1 ml of 0.375% ropivacaine to confirm nerve displacement, the remaining 0.375% ropivacaine was injected (total dose of 20 ml). Subsequently, the catheter was inserted over the needle and the needle was withdrawn.After extubation and the patients were awake, anesthesiologists who were unaware of the study subgroups began to assess the analgesic effect of the patients' block at rest using the numeric pain rating scale (NRS) at 0.5h, 3h, 6h, 12h, 18h, 24h, and 48h postoperatively.

interscalene block

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Shoulder joint surgery in Jiaxing First Hospital from November 2023 to February 2024;
  • Age 18-80 years old;
  • ASA Grade I-III;
  • The duration of surgery is expected to be 1-3h

You may not qualify if:

  • accompanied by nerve injury or disease around the shoulder joint, including thoracic outlet syndrome, Multiple sclerosis, cervical disc disease with ipsilateral radiculopathy, etc.
  • accompanied by abnormal sensory or motor function of the upper limb;
  • Active infection at the puncture site, or coagulation dysfunction (hemophilia, von willeophilia, or International normalized ratio \[INR\]\>2);
  • Patients with severe respiratory diseases and a serious history of cardiovascular and cerebrovascular diseases;
  • ipsilateral shoulder joint surgery history;
  • Patients with nerve block failure;
  • Allergic to local anesthetics;
  • Long-term use of opioids (duration ≥3 months or duration ≥1 month and daily dose ≥5mg morphine equivalent);
  • Operation time \<1h or \>3h
  • Patients and their families refused surgical anesthesia and were unable to complete the questionnaire.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Affiliated Hospital of Jiaxing University

Jiaxing, Zhejiang, 314000, China

Location

Related Publications (1)

  • Kim SH, Yeo IS, Jang J, Jung HE, Chun YM, Yang HM. Infraspinatus-teres minor (ITM) interfascial block: a novel approach for combined suprascapular and axillary nerve block. Reg Anesth Pain Med. 2024 Jan 11;49(1):67-72. doi: 10.1136/rapm-2023-104738.

MeSH Terms

Conditions

Shoulder Pain

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • QINGhe ZHOU

    deputy chair of board

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

January 2, 2024

First Posted

February 5, 2024

Study Start

December 8, 2023

Primary Completion

April 5, 2024

Study Completion

April 12, 2024

Last Updated

July 3, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

research direction

Locations